EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma

BACKGROUND: Immunotherapy is an effective therapeutic approach for multiple human cancer types. However, the correlations between EVA1C and patients’ prognosis as well as immune infiltration remain obscure. Herein, we employed transcriptomic and clinical data extracted from two independent databases...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhicheng, Qu, Shanqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277382/
https://www.ncbi.nlm.nih.gov/pubmed/34267752
http://dx.doi.org/10.3389/fimmu.2021.683572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277382/
https://www.ncbi.nlm.nih.gov/pubmed/34267752
http://dx.doi.org/10.3389/fimmu.2021.683572

Ejemplares similares